| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 24, 2023 4:30 P.M. |
| Form: | F-3 | |||||
|
Attachments
Disclaimer
ADC Therapeutics SA published this content on 24 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 March 2023 10:12:02 UTC.